Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 14/20 | 0.33 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.31 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.30 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.30 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11903329 | 0.89 | MEP1B (0.33) | PTGESMEP1BPRKAG1PRKAA1PRKAB1 | |
| SCHEMBL1656974 | 0.89 | GLP1R (0.35) | MEP1BMAPK1 | |
| SCHEMBL11903085 | 0.87 | MAPT (0.34) | PTGESMAPK1 | |
| SCHEMBL1654723 | 0.86 | NR4A2 (0.36) | MEP1BPRKAG1PRKAA1PRKAB1 | |
| SCHEMBL11903307 | 0.86 | PTGES (0.32) | PTGESMEP1BMAPK1 | |
| SCHEMBL11902404 | 0.85 | L3MBTL1 (0.32) | MEP1B | |
| SCHEMBL11903160 | 0.85 | SMN1; SMN2 (0.32) | PTGESPRKAG1PRKAA1PRKAB1MAPK1 | |
| SCHEMBL11902297 | 0.84 | PTGES (0.36) | PTGESMEP1B | |
| SCHEMBL11902825 | 0.83 | KMO (0.43) | MEP1BPRKAG1PRKAA1PRKAB1 | |
| SCHEMBL11913427 | 0.81 | SMN1; SMN2 (0.37) | PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | DDT, HAO2, HAAO | PTGES 1440/4885MEP1B 2906/4885PRKAG1 2566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.